N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide

C117H134F18N30O12 — CID 159721327

IUPACN-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide
SMILESCCn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.CNc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)cn1.Cc1cc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)n[nH]1.Cn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.Nc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)nc1.O=C(Nc1ccn[nH]1)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1
InChIInChI=1S/C21H24F3N5O2.C20H22F3N5O2.C20H24F3N5O2.2C19H22F3N5O2.C18H20F3N5O2/c1-25-19-5-3-15(13-26-19)27-20(30)29-9-7-28(8-10-29)17-6-11-31-18-12-14(21(22,23)24)2-4-16(17)18;21-20(22,23)13-1-3-15-16(5-10-30-17(15)11-13)27-6-8-28(9-7-27)19(29)26-18-4-2-14(24)12-25-18;1-2-28-18(5-7-24-28)25-19(29)27-10-8-26(9-11-27)16-6-12-30-17-13-14(20(21,22)23)3-4-15(16)17;1-12-10-17(25-24-12)23-18(28)27-7-5-26(6-8-27)15-4-9-29-16-11-13(19(20,21)22)2-3-14(15)16;1-25-17(4-6-23-25)24-18(28)27-9-7-26(8-10-27)15-5-11-29-16-12-13(19(20,21)22)2-3-14(15)16;19-18(20,21)12-1-2-13-14(4-10-28-15(13)11-12)25-6-8-26(9-7-25)17(27)23-16-3-5-22-24-16/h2-5,12-13,17H,6-11H2,1H3,(H,25,26)(H,27,30);1-4,11-12,16H,5-10,24H2,(H,25,26,29);3-5,7,13,16H,2,6,8-12H2,1H3,(H,25,29);2-3,10-11,15H,4-9H2,1H3,(H2,23,24,25,28);2-4,6,12,15H,5,7-11H2,1H3,(H,24,28);1-3,5,11,14H,4,6-10H2,(H2,22,23,24,27)
InChIKeyNABNOXAKTGPWJA-UHFFFAOYSA-N
MW2494.52 g/mol
LogP20.39
Rot. Bonds14

About N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide

N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide (PubChem CID 159721327) has the molecular formula C117H134F18N30O12 and a molecular weight of 2494.52 g/mol. Its IUPAC name is N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide.

Molecular Properties

Compound NameN-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide
PubChem CID159721327
Molecular FormulaC117H134F18N30O12
Molecular Weight2494.52 g/mol
Exact Mass2493.05
IUPAC NameN-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide
SMILESCCn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.CNc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)cn1.Cc1cc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)n[nH]1.Cn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.Nc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)nc1.O=C(Nc1ccn[nH]1)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1
InChIInChI=1S/C21H24F3N5O2.C20H22F3N5O2.C20H24F3N5O2.2C19H22F3N5O2.C18H20F3N5O2/c1-25-19-5-3-15(13-26-19)27-20(30)29-9-7-28(8-10-29)17-6-11-31-18-12-14(21(22,23)24)2-4-16(17)18;21-20(22,23)13-1-3-15-16(5-10-30-17(15)11-13)27-6-8-28(9-7-27)19(29)26-18-4-2-14(24)12-25-18;1-2-28-18(5-7-24-28)25-19(29)27-10-8-26(9-11-27)16-6-12-30-17-13-14(20(21,22)23)3-4-15(16)17;1-12-10-17(25-24-12)23-18(28)27-7-5-26(6-8-27)15-4-9-29-16-11-13(19(20,21)22)2-3-14(15)16;1-25-17(4-6-23-25)24-18(28)27-9-7-26(8-10-27)15-5-11-29-16-12-13(19(20,21)22)2-3-14(15)16;19-18(20,21)12-1-2-13-14(4-10-28-15(13)11-12)25-6-8-26(9-7-25)17(27)23-16-3-5-22-24-16/h2-5,12-13,17H,6-11H2,1H3,(H,25,26)(H,27,30);1-4,11-12,16H,5-10,24H2,(H,25,26,29);3-5,7,13,16H,2,6,8-12H2,1H3,(H,25,29);2-3,10-11,15H,4-9H2,1H3,(H2,23,24,25,28);2-4,6,12,15H,5,7-11H2,1H3,(H,24,28);1-3,5,11,14H,4,6-10H2,(H2,22,23,24,27)
InChIKeyNABNOXAKTGPWJA-UHFFFAOYSA-N
XLogP20.39
TPSA425.69 Ų
H-Bond Donors10
H-Bond Acceptors28
Rotatable Bonds14
Heavy Atoms177
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002494.52
LogP ≤ 520.39
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1028

Analyze N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide?
The IUPAC name of N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide (CID 159721327) is N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide.
What is the SMILES notation for N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide?
The canonical SMILES for N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide is CCn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.CNc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)cn1.Cc1cc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)n[nH]1.Cn1nccc1NC(=O)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.Nc1ccc(NC(=O)N2CCN(C3CCOc4cc(C(F)(F)F)ccc43)CC2)nc1.O=C(Nc1ccn[nH]1)N1CCN(C2CCOc3cc(C(F)(F)F)ccc32)CC1.
What is the InChIKey of N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide?
The InChIKey is NABNOXAKTGPWJA-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H24F3N5O2.C20H22F3N5O2.C20H24F3N5O2.2C19H22F3N5O2.C18H20F3N5O2/c1-25-19-5-3-15(13-26-19)27-20(30)29-9-7-28(8-10-29)17-6-11-31-18-12-14(21(22,23)24)2-4-16(17)18;21-20(22,23)13-1-3-15-16(5-10-30-17(15)11-13)27-6-8-28(9-7-27)19(29)26-18-4-2-14(24)12-25-18;1-2-28-18(5-7-24-28)25-19(29)27-10-8-26(9-11-27)16-6-12-30-17-13-14(20(21,22)23)3-4-15(16)17;1-12-10-17(25-24-12)23-18(28)27-7-5-26(6-8-27)15-4-9-29-16-11-13(19(20,21)22)2-3-14(15)16;1-25-17(4-6-23-25)24-18(28)27-9-7-26(8-10-27)15-5-11-29-16-12-13(19(20,21)22)2-3-14(15)16;19-18(20,21)12-1-2-13-14(4-10-28-15(13)11-12)25-6-8-26(9-7-25)17(27)23-16-3-5-22-24-16/h2-5,12-13,17H,6-11H2,1H3,(H,25,26)(H,27,30);1-4,11-12,16H,5-10,24H2,(H,25,26,29);3-5,7,13,16H,2,6,8-12H2,1H3,(H,25,29);2-3,10-11,15H,4-9H2,1H3,(H2,23,24,25,28);2-4,6,12,15H,5,7-11H2,1H3,(H,24,28);1-3,5,11,14H,4,6-10H2,(H2,22,23,24,27).
What are the key properties of N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide?
N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide has a molecular weight of 2494.52 g/mol, XLogP of 20.39, 14 rotatable bonds, 10 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-amino-2-pyridinyl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-ethylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-[6-(methylamino)-3-pyridinyl]-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(2-methylpyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(5-methyl-1H-pyrazol-3-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide;N-(1H-pyrazol-5-yl)-4-[7-(trifluoromethyl)-3,4-dihydro-2H-chromen-4-yl]piperazine-1-carboxamide is sourced from PubChem (CID 159721327), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).